Raphael Pharmaceutical Inc. (RAPH) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$1.43M | -93.1% |
| 2024 | -$742.0K | -793.5% |
| 2023 | $107.0K | +0.9% |
| 2022 | $106.0K | -17.2% |
| 2021 | $128.0K | +397.7% |
| 2020 | -$43.0K | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$1.43M | -93.1% |
| 2024 | -$742.0K | -793.5% |
| 2023 | $107.0K | +0.9% |
| 2022 | $106.0K | -17.2% |
| 2021 | $128.0K | +397.7% |
| 2020 | -$43.0K | — |